SCHEMBL480432

SCHEMBL480432

COc1ccc(C(=O)CCC(Cc2ccccc2)N(C)C)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.52
BCHE P06276 3/20 0.52
CTNNB1 P35222 2/20 0.50
WNT3A P56704 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HPGD P15428 1/20 0.50
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
PDE4A P27815 2/20 0.45
PDE4B Q07343 2/20 0.45
PDE4C Q08493 2/20 0.45
PDE4D Q08499 2/20 0.45
LMNA P02545 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027864 0.81 CTNNB1 (0.52) ACHEBCHECTNNB1WNT3ANPC1
SCHEMBL4601794 0.78 ACHE (0.73) ACHEBCHECTNNB1WNT3ANPC1
SCHEMBL3054645 0.77 ACHE (0.50) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL3057126 0.77 ACHE (0.50) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL15988928 0.76 CTNNB1 (0.77) ACHECTNNB1WNT3ANPC1RAB9A
SCHEMBL3057121 0.75 ACHE (0.51) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL3054643 0.75 ACHE (0.51) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL7321671 0.75 KMO (0.62) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL1515747 0.75 NPC1 (0.63) ACHEBCHECTNNB1WNT3ANPC1
SCHEMBL8843740 0.75 SMN1; SMN2 (0.64) ACHENPC1RAB9ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1988956-B Process for the photoactivation and use of a catalyst by an inverted two-stage procedure CIBA SC HOLDING AG 2012-10-03 CN claimed
JP-2008506826-A 2008-03-06 JP claimed
US-20070249484-A1 Process for the Photoactivation and use of a Catalyst by an Inverted Two-Stage Procedure CIBA SPECIALTY CHEMICALS CORP. 2007-10-25 US claimed
CN-1988956-A Process for the photoactivation and use of a catalyst by an inverted two-stage procedure CIBA SC HOLDING AG (CH) 2007-06-27 CN claimed
EP-1789188-A2 PROCESS FOR THE PHOTOACTIVATION AND USE OF A CATALYST BY AN INVERTED TWO-STAGE PROCEDURE CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-05-30 EP claimed
WO-2006008251-A2 PROCESS FOR THE PHOTOACTIVATION AND USE OF A CATALYST BY AN INVERTED TWO-STAGE PROCEDURE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-01-26 WO claimed
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2026-05-14 US disclosed
US-12515253-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2026-01-06 US disclosed
US-20250263566-A1 CASTING LACQUER FOR SCREEN PRINTING DE LA RUE INTERNATIONAL LIMITED (GB) 2025-08-21 US disclosed
US-12325806-B2 Photocurable composition for use in 3D printing BASF SE (DE) 2025-06-10 US disclosed
US-12296391-B2 Security element BASF SE (DE) 2025-05-13 US disclosed
EP-4337734-B1 COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES BASF SE (DE) 2025-04-23 EP disclosed
US-12240989-B2 Organomodified metal oxide or metalloid oxide polymer film BASF SE (DE) 2025-03-04 US disclosed
US-20050228062-A1 Incorporable photoinitiator IGM GROUP B.V. (NL) 2005-10-13 US disclosed
CN-1649905-A Incorporable photoinitiators CIBA SC HOLDING AG (CH) 2005-08-03 CN disclosed
EP-1499645-A1 INCORPORABLE PHOTOINITIATOR Ciba SC Holding AG (CH) 2005-01-26 EP disclosed
WO-2004104051-A1 BIMOLECULAR PHOTOINITIATOR SYSTEMS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-12-02 WO disclosed
WO-2004103580-A1 STRONGLY ADHERENT SURFACE COATINGS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-12-02 WO disclosed
WO-2004074328-A1 PHOTOCURABLE COMPOSITIONS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-09-02 WO disclosed
WO-2003091287-A1 INCORPORABLE PHOTOINITIATOR CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS COPE, COPB2, C9 ACHE 3837/4885BCHE 4123/4885CTNNB1 682/4885
US-20070249484-A1 Process for the Photoactivation and use of a Catalyst by an Inverted Two-Stage Procedure INF2, CRY2, CCNT2 ACHE 888/4885BCHE 2040/4885CTNNB1 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.